Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : 30 Covid-19 Deaths in Kenya as 622 New Cases Posted

06/24/2021 | 10:06am EDT

30 more people succumbed to COVID-19 in Kenya Wednesday raising fatalities from the disease in the country to 3,514.

Health Cabinet Secretary Mutahi Kagwe said 29 of the deaths were reported late by health facilities, with only one recorded Tuesday.

622 new infections were also recorded, raising total cases so far to 180,498.

Kagwe said the new cases were confirmed from 6,236 samples tested on Tuesday.

By June 23 Kenya had carried out 1,920,018 COVID tests.

The country's recovery toll rose to 123,363 after 313 more patients were cleared including 107 who were discharged from various health facilities.

Kenya has received 360,000 doses of COVID-19 AstraZeneca vaccine from Denmark, signaling a major boost in the inoculation exercise that started in February.

The vaccines which were given as a donation were received on Monday night by Health Principal Secretary Susan Mochache at the Jomo Kenyatta International Airport (JKIA).

1,190,889 Kenyans have so far been vaccinated, 996,414 having received the first dose while 194,475 received the second dose.

With the new batch of vaccines, Mochache asked Kenyans who have already received their first dose of COVID-19 vaccine to visit various health centres across the country from Wednesday to get their second jab.

"From Wednesday when I am sure the vaccine will have reached most facilities in Kenya we would wish that people should get out and go for their second dose. This vaccine donation that we have received has got a life of about one month and so up to to the end of July the vaccines will be in good condition and can therefore be administered," she said.

Mochache said that the vaccines could not have come at a better time revealing that Kenya's COVID-19 stock had only 5, 000 vaccines remaining.

Kenya kicked off its inoculation exercise in March with 1.02 million doses of the AstraZeneca vaccine that was acquired through the covax facility.

Copyright Capital FM. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

All news about ASTRAZENECA PLC
12:16pMODERNA : says its COVID-19 shot maintains high efficacy through 6 months
07:50aASTRAZENECA : ArisGlobal Highlights R&D Innovation, Digital Transformation, and ..
06:43aAnalysis-Sanofi's COVID-19 vaccine setback, drug pipeline cast long shadow
05:21aASTRAZENECA : DeepMatter to Provide DigitalGlassware Platform to University of C..
05:06aASTRAZENECA : Vaccine to Be Administered to Citizens in Walk-in Vaccination Cent..
08/04ASTRAZENECA : Feds say 82,000-plus doses of AstraZeneca vaccine to be sent to Tr..
08/04ASTRAZENECA : SVB Leerink Adjusts Price Target on AstraZeneca to $69 From $63, M..
08/04ASTRAZENECA : Japan to ship total of 1.6 mil. COVID vaccine doses to Nepal
08/04Thai hospital tycoon who promised Pfizer vaccine says deal now unlikely
08/03ASTRAZENECA : Chilean study shows variations in success of COVID-19 vaccines
More news
Financials (USD)
Sales 2021 35 164 M - -
Net income 2021 5 179 M - -
Net Debt 2021 25 968 M - -
P/E ratio 2021 30,5x
Yield 2021 2,45%
Capitalization 178 B 178 B -
EV / Sales 2021 5,80x
EV / Sales 2022 4,70x
Nbr of Employees 76 100
Free-Float 96,4%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 29
Last Close Price 114,85 $
Average target price 133,84 $
Spread / Average Target 16,5%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC12.92%178 096
JOHNSON & JOHNSON10.15%456 367
ROCHE HOLDING AG14.56%340 460
PFIZER, INC.22.77%252 960
NOVARTIS AG-0.36%223 613